MUMBAI: A day after semaglutide lost patent protection in India, top drugmakers including Dr Reddy’s, Sun Pharma, and Zydus Lifesciences launched generic versions priced...
Indian drugmakers have launched semaglutide injections after the patent on the GLP-1 molecule expired in India on March 20, opening the market to lower-priced...
Abbott India Ltd has partnered with Novo Nordisk to market a new brand of semaglutide in India, the diabetes drug behind blockbuster weight-loss therapy...
Zydus Lifesciences Ltdon Friday, February 27, said its in-licensed pembrolizumab biosimilar has met the primary endpoint in a pivotal pharmacokinetic (PK) study, paving the...